The store will not work correctly when cookies are disabled.
(3-Bromo-benzo[b]thiophen-7-ylmethyl)-(6,6-dimethyl-hept-2-en-4-ynyl)-methyl-amine hydrochloride
ID: ALA545123
PubChem CID: 45262831
Max Phase: Preclinical
Molecular Formula: C19H23BrClNS
Molecular Weight: 376.36
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CN(C/C=C/C#CC(C)(C)C)Cc1cccc2c(Br)csc12.Cl
Standard InChI: InChI=1S/C19H22BrNS.ClH/c1-19(2,3)11-6-5-7-12-21(4)13-15-9-8-10-16-17(20)14-22-18(15)16;/h5,7-10,14H,12-13H2,1-4H3;1H/b7-5+;
Standard InChI Key: QUVHVFSMMVKESP-GZOLSCHFSA-N
Molfile:
RDKit 2D
23 23 0 0 0 0 0 0 0 0999 V2000
5.0889 4.3345 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8749 8.2840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.1713 9.0401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9971 3.0138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5785 7.5278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.4677 9.7963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5842 6.0270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2935 3.7700 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.0907 -2.3426 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2878 5.2708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.4631 10.9963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.5094 9.2006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.5045 10.4005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3352 3.1743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
2 4 1 0
2 5 2 0
4 6 1 0
3 7 1 0
6 7 2 0
8 9 3 0
5 10 1 0
8 11 1 0
9 12 1 0
11 13 2 0
10 14 1 0
6 15 1 0
4 16 2 0
5 17 1 0
13 18 1 0
14 18 1 0
16 19 1 0
17 19 2 0
12 20 1 0
12 21 1 0
12 22 1 0
14 23 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 376.36 | Molecular Weight (Monoisotopic): 375.0656 | AlogP: 5.70 | #Rotatable Bonds: 4 |
Polar Surface Area: 3.24 | Molecular Species: BASE | HBA: 2 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 1 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 8.67 | CX LogP: 6.18 | CX LogD: 4.89 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.62 | Np Likeness Score: -0.22 |
References
1. Nussbaumer P, Petranyi G, Stütz A.. (1991) Synthesis and structure-activity relationships of benzo[b]thienylallylamine antimycotics., 34 (1): [PMID:1992153] [10.1021/jm00105a011] |